Johnson & Johnson (LON: 0R34)

Market Cap	283.98B
Revenue (ttm)	65.44B
Net Income (ttm)	10.96B
Shares Out	n/a
EPS (ttm)	4.51
PE Ratio	25.92
Forward PE	n/a
Dividend	3.85 (2.59%)
Ex-Dividend Date	Feb 18, 2025

Volume	37,655
Average Volume	11,091
Open	148.99
Previous Close	148.20
Day's Range	147.05 - 149.46
52-Week Range	143.14 - 165.71
Beta	n/a
RSI	42.80
Earnings Date	Jan 22, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company’s Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lu...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 131,900
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R34

Financial Performance

In 2023, Johnson & Johnson's revenue was $85.16 billion, an increase of 6.46% compared to the previous year's $79.99 billion. Earnings were $35.15 billion, an increase of 95.94%.

Financial numbers in USD